RAGE signaling regulates the progression of diabetic complications
Diabetes, the ninth leading cause of death globally, is expected to affect 642 million people by 2040. With the advancement of an aging society, the number of patients with diabetes having multiple underlying diseases, such as hypertension, obesity, and chronic inflammation, is increasing. Thus, the...
Main Authors: | Kensei Taguchi, Kei Fukami |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1128872/full |
Similar Items
-
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
by: Matthew Snelson, et al.
Published: (2022-02-01) -
Galectin‐3 and RAGE differentially control advanced glycation endproduct‐induced collagen damage in murine intervertebral disc organ culture
by: Zachary S. Gallate, et al.
Published: (2023-06-01) -
Glucagon-like peptide-1 attenuates diabetes-associated osteoporosis in ZDF rat, possibly through the RAGE pathway
by: Yanzhen Cheng, et al.
Published: (2022-05-01) -
Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts
by: Julio A. Lamprea‐Montealegre, et al.
Published: (2022-08-01) -
Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)